Head of Launch and Marketing Excellence at Acadia Pharmaceuticals

Tokyo, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Bachelor’s degree or equivalent
Over five years of working experience in the pharmaceutical (or relevant) and/or consulting industries
Microsoft Office proficiency: Word, Excel, PowerPoint
Native/fluent in Japanese and business level or above in English (commitment to improving English if needed)
Preferred
Launch experience
Medical Science Degrees or MBA
Experience in Sales, Marketing or Medical Affairs
Experience in oncology and/or gene therapy
Experience of vendor management
Experience in Digital Marketing/communication
Soft skills and mindset
Strategic, logical and critical thinking
Shows Leadership and inclusive
Accountable for assignments
Coachable and passionate for growth
Self-motivated and agile on learning
Own inter-personal skills and collaborative
Cross-functional Project Management

Responsibilities

Pre-launch
Develop and implement a marketing plan: Analyze external environments through market research, collaboration with relevant functions, and external interactions including commercial Advisory board meetings
Identify key issues, barriers, and Key Success Factors
Build strategies and detailed tactics including an annual calendar, events, trainings and promotional materials
Develop and provide extensive sales trainings on diseases, product, account opening etc. in collaboration with Commercial Excellence and Medical Affairs
Develop and track KPIs with Commercial Excellence
Plan and implement pre-launch external activities including building relationship with KOLs in collaboration with Medical Affairs and Public Affairs and Communications
Manage projects on material development and other activities
Conduct necessary internal and external procedures
Attend domestic and international major scientific meetings (mostly with support of Director)
Present the plan to Global Team, Japan Leadership Team and relevant functions
Forecast and manage promotional costs and production
Post-launch
On top of pre-launch activities: Lead post-launch cross-functional brand meetings
Identify room for improvement/growth of relevant functions and figure out how to fill the gaps
Maintain and develop relationships with KOLs and scientific societies
General
Responsible for the business of the gene therapy drug to be launched, including development and implementation of a business plan (independently and/or with support/under supervision of Director)

Skills

Market Research

Marketing Strategy

Sales Training

KOL Management

Business Planning

Forecasting

Microsoft Excel

Microsoft PowerPoint

Microsoft Word

Japanese

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free